Right now, if ECT was required to fund $10M, we wouldn't be able to do that because Brevet would not fully fund it at this stage. If you recall, Brevet agreed to fund the Indian project provided ECT cod get a favorable overseas R&D tax ruling. At this stage ECT has only got a favorable overseas ruling for Coldry - not for Matmor.
Not sure if the overseas tax ruling for Matmor has stalled or is still in progress. Maybe they paused it given the Indians are now fully funding the project.
- Forums
- ASX - By Stock
- ECT
- Ann: India Project Proceeds to Next Stage
Ann: India Project Proceeds to Next Stage, page-349
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECT (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
-0.001(14.3%) |
Mkt cap ! $9.515M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $6 | 1.859K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
54 | 14660396 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 12520617 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
54 | 14660396 | 0.003 |
22 | 14565353 | 0.002 |
12 | 18569024 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 12520617 | 23 |
0.005 | 4502313 | 27 |
0.006 | 5239567 | 10 |
0.007 | 1118334 | 6 |
0.008 | 332213 | 4 |
Last trade - 10.02am 16/07/2024 (20 minute delay) ? |
Featured News
ECT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online